CD38 monoclonal antibodies

Darzalex 400 mg/20 mL (20 mg/mL) injection Images

Generic Name: daratumumab

This medication has been identified as Darzalex 400 mg/20 mL (20 mg/mL) injection. It is supplied by Janssen Biotech, Inc.

Darzalex is used in the treatment of Multiple Myeloma and belongs to the drug class CD38 monoclonal antibodies. Darzalex 400 mg/20 mL (20 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).

Images

Darzalex (Daratumumab [ dar-a-toom-ue-mab ])-medicine-400 mg/20 mL (20 mg/mL) injection

Darzalex
Generic Name: daratumumab [ dar-a-toom-ue-mab ]
Imprint: medicine
Strength: 400 mg/20 mL (20 mg/mL) injection
Color: N/A
Size: N/A
Shape: N/A
Availability: Prescription only
Drug Class: CD38 monoclonal antibodies
Pregnancy Category: N/A
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): 57894-0502
Inactive Ingredients:
Latest News
Related Drugs